Mednet and EMB Statistical Solutions (EMB) have entered a three-year agreement to provide a comprehensive suite of cloud-based eClinical services to EMB customers. The new agreement expands an existing relationship between the two organizations and will provide sponsors with a comprehensive and competitive suite of services.
"New sources of data, emerging technologies and scientific advances are creating rapid transformation in clinical trials and study protocols are becoming increasingly complex," said Brenda Bishop, director of business development, EMB. "We believe Mednet can help us effectively provide value to our customers. Our new agreement extends our commitment and provides our clients with highly flexible and competitive capabilities that easily adapt to their evolving needs."
Mednet and EMB will provide clinical trial sponsors with a combination of therapeutic and clinical trial study design expertise, along with comprehensive and flexible technology to increase the speed of study design, build and execution.
"We're excited about the new, expanded agreement with EMB to deliver comprehensive eClinical capabilities to clinical trial sponsors," said Rick Bernstein, chief commercial officer, Mednet. "We believe our highly flexible and comprehensive all-in-one eClinical solution combined with EMB's broad and deep clinical research experience will enable life sciences companies to accelerate clinical development."